A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Zhejiang University
Celon Pharma SA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Multitude Therapeutics Inc.
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Seoul National University Hospital
BGI, China
Zhongnan Hospital
Impact Therapeutics, Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Northwell Health
Revolution Medicines, Inc.
Imperial College London
Fudan University
Corregene Biotechnology Co., Ltd
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
West China Second University Hospital
Peking University People's Hospital
West China Second University Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sun Yat-sen University
Ruijin Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Huazhong University of Science and Technology
Hebei Senlang Biotechnology Inc., Ltd.
Lee's Pharmaceutical Limited
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Ruijin Hospital
Massachusetts General Hospital
Lee's Pharmaceutical Limited
Hunan Cancer Hospital
Shenzhen People's Hospital
GOG Foundation
Critical Outcome Technologies Inc.
Placon Therapeutics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Mie University
British Columbia Cancer Agency
Merrimack Pharmaceuticals
Oncolix, Inc.
Huazhong University of Science and Technology
Huazhong University of Science and Technology
Asan Medical Center
Samyang Biopharmaceuticals Corporation
Beijing Chaoyang District Centre for Disease Control and Prevention
Shenzhen Second People's Hospital